Rearranged EML4-ALK fusion transcripts sequester in circulating blood platelets and enable blood-based crizotinib response monitoring in non-small-cell lung cancer

R. Jonas A. Nilsson, Niki Karachaliou, Jordi Berenguer, Ana Gimenez-Capitan, Pepijn Schellen, Cristina Teixido, Jihane Tannous, Justine L. Kuiper, Esther Drees, Magda Grabowska, Marte van Keulen, Danielle A. M. Heideman, Erik Thunnissen, Anne-Marie C. Dingemans, Santiago Viteri, Bakhos A. Tannous, Ana Drozdowskyj, Rafael Rosell, Egbert F. Smit, Thomas Wurdinger

Research output: Contribution to journalArticleAcademicpeer-review

Original languageEnglish
Pages (from-to)1066-1075
JournalOncotarget
Volume7
Issue number1
DOIs
Publication statusPublished - 5 Jan 2016

Keywords

  • diagnostics
  • NSCLC
  • liquid biopsies
  • platelets
  • EML4-ALK

Cite this

Nilsson, R. J. A., Karachaliou, N., Berenguer, J., Gimenez-Capitan, A., Schellen, P., Teixido, C., Tannous, J., Kuiper, J. L., Drees, E., Grabowska, M., van Keulen, M., Heideman, D. A. M., Thunnissen, E., Dingemans, A-M. C., Viteri, S., Tannous, B. A., Drozdowskyj, A., Rosell, R., Smit, E. F., & Wurdinger, T. (2016). Rearranged EML4-ALK fusion transcripts sequester in circulating blood platelets and enable blood-based crizotinib response monitoring in non-small-cell lung cancer. Oncotarget, 7(1), 1066-1075. https://doi.org/10.18632/oncotarget.6279